信原クリニック たつの. Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease. Heretics part of speech. Jang Sung-woo short track.
信原クリニック たつの. Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease. Heretics part of speech. Jang Sung-woo short track.